Clinical Trials Logo

Clinical Trial Summary

1. Compares and evaluates the relative bioavailability of single-dose subcutaneous administration of each of the Eutropin formulations to healthy male volunteers.

2. Ensure safety and tolerability of single, subcutaneous administration of Eutropin formulations to healthy male volunteers.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03154840
Study type Interventional
Source LG Chem
Contact
Status Active, not recruiting
Phase Phase 1
Start date May 31, 2017
Completion date November 30, 2017

See also
  Status Clinical Trial Phase
Completed NCT02052349 - Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects Phase 1
Completed NCT01911741 - A Study to Compare Capsule and Tablet Forms of MDV3100 (Enzalutamide) After Administration of a Single Set Dose Under Fasted Conditions in Healthy Male Subjects Phase 1
Completed NCT04814472 - Healthy Volunteer Study Comparing Tablet and Oral Solution Formulations Phase 1
Completed NCT03934333 - A Study to Compare the Pharmacokinetics of Budesonide Delivered by PT027 Compared With Pulmicort Flexhaler (ELBRUS) Phase 1
Not yet recruiting NCT06025344 - A Relative Bioavailability Study With a Novel PanCytoVirâ„¢ Oral Suspension (100 mg/ml) Phase 1
Not yet recruiting NCT06025318 - An Evaluation of the Effect of Food on the PK of a Novel PanCytoVirâ„¢ Suspension (100mg/ml), in Healthy, Adult Volunteers Phase 1
Completed NCT04686669 - A Relative Bioavailability Study of FOR-6219 in Capsule and Tablet Formulations Phase 1
Completed NCT03483259 - To Explore the Pharmacokinetics and Relative Bioavailability of Sulfatinib Capsules in Two Different Manufacturers Phase 1
Completed NCT05296382 - Bioavailability of Tebipenem (SPR994) Crushed Tablet Phase 1